Literature DB >> 20942392

Investigation of the relationship between topology and selectivity for druglike molecules.

Yidong Yang1, Hongming Chen, Ingemar Nilsson, Sorel Muresan, Ola Engkvist.   

Abstract

There is a strong interest in drug discovery and development to advance the understanding of pharmacological promiscuity. Improved understanding of how a molecular structure is related to promiscuity could help to reduce the attrition of compounds in the drug discovery process. For this purpose, a descriptor is introduced that describes the structural complexity of a compound based on the size of its molecular framework (MF) in relation to its overall size. It is defined as the fraction of the size of the molecular framework versus the size of the whole molecule (f(MF)). It is demonstrated that promiscuity correlates with f(MF) for large f(MF) values. The observed correlation is not due to lipophilicity. To provide further explanation of this observation, it was found that the number of terminal ring systems in a compound is correlated with promiscuity. The analysis presented here might help medicinal chemists to improve the selectivity for compounds in drug discovery projects.

Mesh:

Substances:

Year:  2010        PMID: 20942392     DOI: 10.1021/jm1008456

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

2.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

3.  Identification of Effective and Nonpromiscuous Antidiabetic Drug Molecules from Penicillium Species.

Authors:  Shahzad Saleem; Shabana Bibi; Qudsia Yousafi; Tehzeem Hassan; Muhammad Saad Khan; Mohammad Mehedi Hasan; Hitesh Chopra; Mahmoud Moustafa; Mohammed Al-Shehri; Mohammad Khalid; Atul Kabra
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

4.  A theoretical entropy score as a single value to express inhibitor selectivity.

Authors:  Joost C M Uitdehaag; Guido J R Zaman
Journal:  BMC Bioinformatics       Date:  2011-04-12       Impact factor: 3.169

5.  Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds.

Authors:  Christopher Southan; Kiran Boppana; Sarma Arp Jagarlapudi; Sorel Muresan
Journal:  J Cheminform       Date:  2011-05-13       Impact factor: 5.514

Review 6.  Rational approaches to improving selectivity in drug design.

Authors:  David J Huggins; Woody Sherman; Bruce Tidor
Journal:  J Med Chem       Date:  2012-01-12       Impact factor: 7.446

7.  Badapple: promiscuity patterns from noisy evidence.

Authors:  Jeremy J Yang; Oleg Ursu; Christopher A Lipinski; Larry A Sklar; Tudor I Oprea; Cristian G Bologa
Journal:  J Cheminform       Date:  2016-05-28       Impact factor: 5.514

8.  CReM: chemically reasonable mutations framework for structure generation.

Authors:  Pavel Polishchuk
Journal:  J Cheminform       Date:  2020-04-22       Impact factor: 5.514

9.  SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity Data.

Authors:  Mats Eriksson; Ingemar Nilsson; Thierry Kogej; Christopher Southan; Martin Johansson; Christian Tyrchan; Sorel Muresan; Niklas Blomberg; Marcus Bjäreland
Journal:  Mol Inform       Date:  2012-08-07       Impact factor: 3.353

10.  The development of models to predict melting and pyrolysis point data associated with several hundred thousand compounds mined from PATENTS.

Authors:  Igor V Tetko; Daniel M Lowe; Antony J Williams
Journal:  J Cheminform       Date:  2016-01-22       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.